@American_Heart’s official account for meetings, science news, funding opportunities and membership. RTs/Follows not endorsements. Pump up your career, here.

Dallas, TX
Joined January 2009
Ready to jumpstart your research career? If you’re in the early years of your first professional appointment, this grant will support your research, training and mentorship to ensure your future success as a research scientist. Apply today. 👇 Find more information on this opportunity here: bit.ly/4jr4DTi
1
3
5
1,193
New programming formats, expanded learning opportunities and innovative experiences make #ScientificSessions26 a must-attend event. Join us in Chicago for 4-days of science. 2026 Chairs: @JoChikweMD, @bnallamo Register now: bit.ly/458Naqj
5
9
1,228
Congratulations to Lawrence J. Appel, M.D., M.P.H., FAHA, recipient of the 2026 Research Achievement Award! 🏆 From the landmark DASH trials to decades of research in hypertension, nutrition and cardiovascular prevention, Dr. Appel’s work has transformed our understanding of heart health and helped shape care around the world. His scientific contributions continue to improve the prevention and treatment of cardiovascular disease for millions. Learn more: bit.ly/47GWp22
4
12
1,092
Congratulations to @emilyswlau, M.D., M.P.H., FAHA, recipient of the 2026 Dr. Nanette K. Wenger Research Goes Red® Award for Best Scientific Article on Cardiovascular Disease and Stroke in Women. 🏆 Through groundbreaking research on cardiovascular health and pregnancy, Dr. Lau is helping advance our understanding of heart disease in women and inform better prevention and care for future generations. Join us in celebrating this well-deserved recognition. 👏 Learn More: bit.ly/4rK3CHS
10
20
1,605
Discover science you can apply immediately to your practice, research and leadership at #ScientificSessions26. Register today: bit.ly/458Naqj
1
526
📣 A quick reminder before Scientific Sessions 2026 begins. 🔽 The official event hashtag is #ScientificSessions26. Help attendees, presenters, and the broader cardiovascular community find your posts by tagging your content with #ScientificSessions26 throughout the meeting.
1
1
8
1,185
How do you balance Alzheimer's disease treatment with the need for anticoagulation or antithrombotic therapy? The framework highlights the importance of multidisciplinary collaboration among neurology, cardiology, pharmacy, primary care, and other clinical teams to support individualized treatment decisions. It also identifies key evidence gaps that will require future research as antiamyloid therapies become more integrated into clinical practice. More here in @JAHA: ahajournals.org/doi/10.1161/… @SMGreenbergNeur @costantinoiade1 @SherryChou399 @MitchElkind @BJHicksMD @lauren_massimo @sudha_md @KristineYaffe @k_sauser
5
20
1,441
📣 #EPILifestyle27 registration is now open! The best in population and global cardiovascular health science will be presented this Mar. in Boston! Meet your colleagues here, Mar. 1-4. #EPILifestyle27 Chairs: Elisabeth Lilian Pia Sattler, PhD, RPh, FAHA; Sonia Y. Angell, MD, MPH Register Today: bit.ly/47iKlnC
1
1
665
Join attendees from more than 100 countries at #ScientificSessions26 and connect with the people driving cardiovascular science forward. 2026 Chairs: @JoChikweMD, @bnallamo Register now: bit.ly/458Naqj
1
7
14
1,381
Tag someone you’re excited to meet up with! We can’t wait to see all your smiling faces in Chicago this November. #ScientificSessions26 #ReSS26 📸 #AHA25
2
1
660
Management of ASCVD should emphasize CKM syndrome comorbidities, including obesity treatment through lifestyle modification, pharmacotherapy, and, when appropriate, metabolic and bariatric surgery; the use of cardioprotective antihyperglycemic agents for T2D; and the use of kidney-protective agents for CKD to reduce the risk for adverse cardiovascular events and loss of kidney function. professional.heart.org/en/sc…
1
15
33
2,284
📣This year at #ScientificSession26. Hear from global leaders and partners about scalable approaches that can help improve cardiovascular outcomes around the world. Join the Paul Dudley White International Lecture and listen to a distinguished lineup of speakers representing the American Heart Association’s global partners. Register today: bit.ly/458Naqj
1
3
7
984
Antiplatelet therapy is foundational for acute coronary syndromes (ACS) and chronic coronary disease (CCD), but medication selection, dose, and duration should be individualized by thrombotic and bleeding risk. Guideline-based therapy remains the foundation of antiplatelet management, with dual antiplatelet therapy (DAPT) duration and P2Y12 inhibitor selection tailored to the clinical scenario. This scientific statement reviews contemporary antiplatelet management in ACS and chronic coronary disease, emphasizing individualized thrombotic and bleeding risk assessment, multidisciplinary care, and antithrombotic stewardship across the care continuum. 📷 Multidisciplinary care in antithrombotic management of acute coronary syndrome and CCD. Link in replies.
3
63
1
180
7,247